Cambridge, Massachusetts-based Oncorus Inc, an oncolytic virus company, has raised $79.5 million in Series B financing. Cowen Healthcare Investments and Perceptive Advisors led the round.
Source: Press Release
Cambridge, Massachusetts-based Oncorus Inc, an oncolytic virus company, has raised $79.5 million in Series B financing. Cowen Healthcare Investments and Perceptive Advisors led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.